Genetic Causes of Stent Thrombosis

Overview

About this study

The purpose of this study is to identify novel genetic variants associated with stent thrombosis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who underwent percutaneous coronary intervention
  • Diagnosis of stent thrombosis.
  • Age >18 years.

Exclusion Criteria: 

  • Patients who denied research authorization
  • Pregnant women

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Charanjit Rihal, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20308368

Mayo Clinic Footer